TSHA
Taysha Gene Therapies, Inc. · Healthcare
0.00
0.00%(+0.00)
Prev. CloseLast Updated: — ET
52W L: $0.0052W H: $0.00
TSHA (1h)
Taysha Gene Therapies, Inc. · Healthcare
Alam Kamran
officer: CHIEF FINANCIAL OFFICER
1,655 SH @ $4.52
2026-02-04
Nagendran Sukumar
director, officer: President and Head of R&D
89,132 SH @ $4.75
2026-01-23
Nagendran Sukumar
director, officer: President and Head of R&D
| 15.5M |
| -72.4M |
| -111.6M |
| -0.96 |
| 2022-12 | 2.5M | 15K | -126M | -166M | -3.78 |
| 2021-12 | 0 | 0 | -173.3M | -174.5M | -4.64 |
26,918 SH @ $4.61
2026-01-26
Nolan Sean P.
director, officer: Chief Executive Officer
136,789 SH @ $4.75
2026-01-23
Nolan Sean P.
director, officer: Chief Executive Officer
41,312 SH @ $4.61
2026-01-26
Alam Kamran
officer: CHIEF FINANCIAL OFFICER
78,968 SH @ $4.75
2026-01-23
Alam Kamran
officer: CHIEF FINANCIAL OFFICER
23,849 SH @ $4.61
2026-01-26
Alam Kamran
officer: CHIEF FINANCIAL OFFICER
359,000 SH @ $0.00
2026-01-12